The Lundquist Institute at Harbor-UCLA Medical Center Administers First Phase 3 AstraZeneca Trial Injection

First participants received the shot at The Lundquist Institute on Friday, September 4; more injections scheduled next week

LOS ANGELES – The Lundquist Institute at Harbor-UCLA Medical Center officially began phase 3 trials of the Oxford University – AstraZeneca COVID-19 vaccine trial on Friday, September 4.